The Role of Autophagy in Pancreatic Cancer—Recent Advances

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers with a 5-year survival rate of only 9%, despite ongoing efforts to improve treatment. This dismal prognosis is due to the difficulty of early stage diagnosis, drug resistance, and likelihood of metastasis development. It is therefore of great importance to identify appropriate therapeutic targets and gain a greater understanding of PDAC biology. Autophagy is a membrane-mediated degradation and recycling mechanism, which is crucial for cell homeostasis. There is evidence for both a tumor-suppressive and a tumor-promoting role of autophagy in cancer, and this is likely context dependent. Within PDAC, a large body of evidence points towards autophagy being required for tumor survival and metabolism. In this review, we describe the recent advances in the understanding of the role and regulation of autophagy in PDAC.

[1]  Yi-Fan Jiang,et al.  Kisspeptin-Activated Autophagy Independently Suppresses Non-Glucose-Stimulated Insulin Secretion from Pancreatic β-Cells , 2019, Scientific Reports.

[2]  Shounan Lu,et al.  Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy , 2019, Journal of cellular physiology.

[3]  S. Piccolo,et al.  Cell phenotypic plasticity requires autophagic flux driven by YAP/TAZ mechanotransduction , 2019, Proceedings of the National Academy of Sciences.

[4]  M. Berger,et al.  Optineurin downregulation induces endoplasmic reticulum stress, chaperone-mediated autophagy, and apoptosis in pancreatic cancer cells , 2019, Cell Death Discovery.

[5]  I. Castellano,et al.  Sulfur-containing histidine compounds inhibit γ-glutamyl transpeptidase activity in human cancer cells , 2019, The Journal of Biological Chemistry.

[6]  Tao Zhang,et al.  UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1 , 2019, Journal of experimental & clinical cancer research : CR.

[7]  D. V. Von Hoff,et al.  Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial. , 2019, JAMA oncology.

[8]  E. White,et al.  Role of tumor and host autophagy in cancer metabolism , 2019, Genes & development.

[9]  Chao Yang,et al.  The role of necroptosis in cancer biology and therapy , 2019, Molecular Cancer.

[10]  Eugene J Koay,et al.  Early Detection of Pancreatic Cancer: Opportunities and Challenges. , 2019, Gastroenterology.

[11]  T. Du,et al.  Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer , 2019, Cellular and Molecular Life Sciences.

[12]  A. Snijders,et al.  ATG9A shapes the forming autophagosome through Arfaptin 2 and phosphatidylinositol 4-kinase IIIβ , 2019, The Journal of cell biology.

[13]  Woosuk Kim,et al.  Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion , 2019, Proceedings of the National Academy of Sciences.

[14]  Caihong Wang,et al.  SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer. , 2019, Biochemical and biophysical research communications.

[15]  E. Petricoin,et al.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer , 2019, Nature Medicine.

[16]  Tongmin Wang,et al.  ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  T. Korcsmáros,et al.  MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma. , 2019, Cancer research.

[18]  S. Lowe,et al.  MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival , 2019, Proceedings of the National Academy of Sciences.

[19]  J. Yap,et al.  Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers , 2019, Nature Medicine.

[20]  M. Radomski,et al.  New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Adenocarcinoma Cell Lines , 2019, International journal of molecular sciences.

[21]  E. Vellenga,et al.  The multifaceted role of autophagy in cancer and the microenvironment , 2018, Medicinal research reviews.

[22]  Wei Zhang,et al.  Long non-coding RNA SNHG14 exerts oncogenic functions in non-small cell lung cancer through acting as an miR-340 sponge , 2018, Bioscience reports.

[23]  Channing J Der,et al.  KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. , 2018, Cold Spring Harbor perspectives in medicine.

[24]  I. Dikic,et al.  Mechanism and medical implications of mammalian autophagy , 2018, Nature reviews. Molecular cell biology.

[25]  David A. Tumbarello,et al.  Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy , 2018, Front. Immunol..

[26]  Tingyi Sun.  Long noncoding RNAs act as regulators of autophagy in cancer , 2017, Pharmacological research.

[27]  M. Falasca,et al.  Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies , 2017, International journal of molecular sciences.

[28]  K. Ryan,et al.  Molecular Pathways Controlling Autophagy in Pancreatic Cancer , 2017, Front. Oncol..

[29]  P. Codogno,et al.  The Journey of the Autophagosome through Mammalian Cell Organelles and Membranes. , 2017, Journal of molecular biology.

[30]  K. Macleod,et al.  Autophagy in cancer metastasis , 2016, Oncogene.

[31]  L. Cantley,et al.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.

[32]  Gregory McAllister,et al.  Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy , 2015, Proceedings of the National Academy of Sciences.

[33]  Mason R. Mackey,et al.  Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress , 2015, Proceedings of the National Academy of Sciences.

[34]  K. Ross,et al.  Transcriptional control of the autophagy-lysosome system in pancreatic cancer , 2015, Nature.

[35]  T. Chiu,et al.  Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine , 2015, Molecular Cancer.

[36]  M. Helmer-Citterich,et al.  Corrigendum: AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation , 2015, Nature Cell Biology.

[37]  M. Helmer-Citterich,et al.  AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-MYC dephosphorylation and degradation , 2014, Nature Cell Biology.

[38]  N. Mizushima,et al.  Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells , 2014, Journal of Cell Science.

[39]  Haitao Zhu,et al.  Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia. , 2014, Oncology reports.

[40]  J. Meyerhardt,et al.  Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. , 2014, The oncologist.

[41]  Gerald C. Chu,et al.  Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. , 2014, Cancer discovery.

[42]  Jun Yu,et al.  GdX/UBL4A specifically stabilizes the TC45/STAT3 association and promotes dephosphorylation of STAT3 to repress tumorigenesis. , 2014, Molecular cell.

[43]  A. Kalergis,et al.  Gap Junction Intercellular Communications Regulate NK Cell Activation and Modulate NK Cytotoxic Capacity , 2014, The Journal of Immunology.

[44]  Amy Y. M. Au,et al.  p53 status determines the role of autophagy in pancreatic tumour development , 2013, Nature.

[45]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[46]  B. Cornelissen,et al.  Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation , 2012, Cell Death and Disease.

[47]  Peter Schemmer,et al.  Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment , 2012, The Journal of pathology.

[48]  M. Vaccaro,et al.  Novel AKT1-GLI3-VMP1 Pathway Mediates KRAS Oncogene-induced Autophagy in Cancer Cells* , 2012, The Journal of Biological Chemistry.

[49]  Hui-Hua Li,et al.  Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells , 2012, Journal of cellular physiology.

[50]  R. Camp,et al.  Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome , 2011, Clinical Cancer Research.

[51]  N. Mizushima,et al.  The role of Atg proteins in autophagosome formation. , 2011, Annual review of cell and developmental biology.

[52]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[53]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[54]  N. Mizushima,et al.  Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins , 2010, Autophagy.

[55]  R. Hegde,et al.  A Ribosome-Associating Factor Chaperones Tail-Anchored Membrane Proteins , 2010, Nature.

[56]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[57]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[58]  C. Mantzoros,et al.  Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice. , 2019, Gastroenterology.

[59]  H. Friess,et al.  The role of inflammation in pancreatic cancer. , 2014, Advances in experimental medicine and biology.